Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unusual primary prostatic malignancies.

M D Efros1, J Fischer, C Mallouh

  • 1Department of Urology, New York Medical College, Valhalla.

Urology
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of cell cycle regulatory proteins and modulation of STAT1 proteins by IFN-gamma in human prostatic JCA-1 cells.

International journal of oncology·2011
Same author

Role of cathepsin D in prostatic cancer cell growth and its regulation by brefeldin A.

World journal of urology·2001
Same author

Glyoxalase I phenotype as a potential risk factor for prostate carcinoma.

Urology·2001
Same author

Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide).

Molecular urology·2000
Same author

Adverse effects of oxidative stress on renal cells and its prevention by antioxidants.

Molecular urology·2000
Same author

Methylglyoxal-induced apoptosis in human prostate carcinoma: potential modality for prostate cancer treatment.

European urology·2000

Atypical prostate cancer, rare malignancies excluding acinar adenocarcinoma, are poorly understood. Reporting new cases helps elucidate their natural history and define treatments.

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Atypical prostate cancer comprises rare malignancies distinct from common acinar adenocarcinoma.
  • These rare cancers represent less than 5% of all prostate malignancies.
  • Limited data exists on the biologic behavior and treatment of atypical prostate cancers due to their rarity.

Observation:

  • This report details five new cases of atypical prostate cancer.
  • The cases contribute to the scarce existing literature on these uncommon tumors.

Findings:

  • The study describes the occurrence of five new cases of atypical prostate cancer.
  • These new cases add to the limited understanding of atypical prostate cancer.

Implications:

Related Experiment Videos

  • Increased reporting of atypical prostate cancer cases can enhance understanding of their natural history.
  • Further research may lead to the development of specific treatment protocols for these rare malignancies.